Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marc C. Daniels"'
Autor:
Leon F. Hebert, Jiping Tang, Donald A. McClain, Robert C. Cooksey, Marc C. Daniels, Errol D. Crook, Geddati Veerababu, Rosemary T. Hoffman
Publikováno v:
Diabetes. 49:2070-2078
To examine the effect of increased hexosamine flux in liver, the rate-limiting enzyme in hexosamine biosynthesis (glutamine:fructose-6-phosphate amidotransferase [GFA]) was overexpressed in transgenic mice using the PEPCK promoter. Liver from random-
Publikováno v:
Journal of Biological Chemistry. 275:31847-31856
Transcription of the phosphoenolpyruvate carboxykinase (PEPCK) gene is regulated by a variety of agents. Glucocorticoids, retinoic acid, and glucagon (via its second messenger, cAMP) stimulate PEPCK gene transcription, whereas insulin, phorbol esters
Publikováno v:
The American Journal of the Medical Sciences. 319:138-142
Background: The hexosamine biosynthesis pathway (HBP) is hypothesized to mediate many of the adverse effects of hyperglycemia. We have shown previously that increased flux through this pathway leads to induction of the growth factor transforming grow
Autor:
Hannele Yki-Järvinen, Marc C. Daniels, Antti Virkamäki, Donald A. McClain, W.Kirby Gottschalk
Publikováno v:
Metabolism. 47:449-455
O-linked N-acetylglucosamine (O-GlcNAc) is an abundant posttranslational modification of serine/threonine residues of nuclear and cytoplasmic proteins. We determined whether insulin or coinfusion of glucosamine (GlcN) with insulin alters O-GlcNAc of
Autor:
Marc C. Daniels, Antti Virkamäki, Hannele Yki-Järvinen, Sari Hämäläinen, Donald A. McClain, Tapio Utriainen
Publikováno v:
Endocrinology. 138:2501-2507
We determined the effect of infusion of glucosamine (GlcN), which bypasses the rate limiting reaction in the hexosamine pathway, on insulin-stimulated rates of glucose uptake and glycogen synthesis in vivo in rat tissues varying with respect to their
Autor:
Lawrence J. Mandarino, Christoph Vogt, Patricia Iozzo, Sari Mäkimattila, H YkiJarvinen, Donald A. McClain, Antti Virkamäki, Ruben Pipek, William K. Gottschalk, Ralph A. DeFronzo, Marc C. Daniels
Publikováno v:
Diabetologia. 40:76-81
Glutamine:fructose 6-phosphate amidotransferase (GFA) is rate-limiting for hexosamine biosynthesis, while a UDP-GlcNAc beta-N-acetylglucosaminyltransferase (O-GlcNAc transferase) catalyses final O-linked attachment of GlcNAc to serine and threonine r
Publikováno v:
Diabetes. 44:314-320
The hexosamine biosynthesis pathway has been hypothesized to mediate some of the regulatory as well as the deleterious effects of glucose. We have stably overexpressed the cDNA for human glutamine:fructose-6-phosphate amidotransferase (GFA), the rate
Autor:
J. Jason Collier, Jill R. Schurr, Donald K. Scott, Marc C. Daniels, Jay K. Kolls, Thuy-Trang T. Doan
Publikováno v:
The Journal of biological chemistry. 278(8)
Glucose exerts powerful effects on hepatocyte gene transcription by mechanisms that are incompletely understood. c-Myc regulates hepatic glucose metabolism by increasing glycolytic enzyme gene transcription while concomitantly decreasing gluconeogeni
Publikováno v:
The American journal of the medical sciences. 319(3)
The hexosamine biosynthesis pathway (HBP) is hypothesized to mediate many of the adverse effects of hyperglycemia. We have shown previously that increased flux through this pathway leads to induction of the growth factor transforming growth factor-al
Autor:
E A Gulve, Jianxin Zhou, Q K Huynh, R T Hoffman, Donald A. McClain, Marc C. Daniels, Errol D. Crook
Publikováno v:
Diabetes. 47(12)
Glutamine:fructose-6-phosphate amidotransferase (GFA) is the rate-limiting enzyme in hexosamine biosynthesis, an important pathway for cellular glucose sensing. Human GFA has two potential sites for phosphorylation by cAMP-dependent protein kinase A